Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 1

Status

Recruiting 18Active not recruiting 13Completed 3Withdrawn 2Terminated 1Not yet recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Neoplasm Metastasis 1Breast Neoplasms 1Advanced Solid Tumor 1

Interventions

pembrolizumab 244Nivolumab 140Cisplatin 135Cyclophosphamide 134Paclitaxel 113Carboplatin 108Gemcitabine 98Radiotherapy 83Dexamethasone 83Docetaxel 77atezolizumab 68Ipilimumab 68Doxorubicin 62Fluorouracil 60Blood Specimen Collection 58Bevacizumab 58fludarabine 54Rituximab 54Etoposide 53Oxaliplatin 52Surveys and Questionnaires 49Lenalidomide 49Prednisone 47Standard of Care 45Magnetic Resonance Spectroscopy 45Cetuximab 44Capecitabine 44lenvatinib 43Radiosurgery 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × talazoparib × 1 year × Clear all
NCT04991480 2026-01-27

A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors

Artios Pharma Ltd

Phase 1 Completed
93 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT04019327 2025-12-15

A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
16 enrolled
Genitourinary

Prostatic Neoplasms

NCT04497116 2025-10-21

TRESR

Repare Therapeutics

Phase 1/2 Completed
276 enrolled 33 charts
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡